|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
6/14/2013
|
ARMEN GARO H
|
Chairman & CEO
|
57,541
|
$3.70
|
6.16%
|
|
6/3/2013
|
ARMEN GARO H
|
Chairman & CEO
|
3,110
|
$4.24
|
0.33%
|
|
5/1/2013
|
ARMEN GARO H
|
Chairman & CEO
|
3,037
|
$4.35
|
0.33%
|
|
4/1/2013
|
ARMEN GARO H
|
Chairman & CEO
|
3,117
|
$4.23
|
0.34%
|
|
3/1/2013
|
ARMEN GARO H
|
Chairman & CEO
|
2,964
|
$4.45
|
0.32%
|
|
2/1/2013
|
ARMEN GARO H
|
Chairman & CEO
|
3,154
|
$4.18
|
0.34%
|
|
1/30/2013
|
Sharp Shalini
|
Director
|
-288
|
$4.36
|
-0.35%
|
|
1/28/2013
|
KLASKIN CHRISTINE M
|
VP, Finance
|
417
|
$4.35
|
1.79%
|
|
1/28/2013
|
ARMEN GARO H
|
Chairman & CEO
|
1,389
|
$4.35
|
0.15%
|
|
1/28/2013
|
Valentine Karen
|
VP, General Counsel
|
417
|
$4.35
|
1.44%
|
|
1/28/2013
|
Sharp Shalini
|
Director
|
625
|
$4.35
|
0.77%
|
|
1/28/2013
|
Wentworth Kerry
|
VP, Clin, Reg & Quality
|
694
|
$4.35
|
1.89%
|
|
1/2/2013
|
ARMEN GARO H
|
Chairman & CEO
|
3,303
|
$4.00
|
0.36%
|
|
12/24/2012
|
ARMEN GARO H
|
Chairman & CEO
|
250,277
|
$4.33
|
37.74%
|
|
12/3/2012
|
ARMEN GARO H
|
Chairman & CEO
|
3,320
|
$3.98
|
0.50%
|
|
11/1/2012
|
ARMEN GARO H
|
Chairman & CEO
|
2,872
|
$4.60
|
0.44%
|
|
10/31/2012
|
Sharp Shalini
|
Director
|
-288
|
$4.40
|
-0.35%
|
|
10/26/2012
|
Wentworth Kerry
|
VP Clin, Reg & Quality
|
695
|
$4.42
|
1.93%
|
|
10/26/2012
|
Valentine Karen
|
VP General Counsel
|
417
|
$4.42
|
1.46%
|
|
10/26/2012
|
Sharp Shalini
|
Director
|
625
|
$4.42
|
0.78%
|
|
10/26/2012
|
ARMEN GARO H
|
Chairman & CEO
|
1,388
|
$4.42
|
0.21%
|
|
10/26/2012
|
KLASKIN CHRISTINE M
|
VP Finance
|
417
|
$4.42
|
1.82%
|
|
10/1/2012
|
ARMEN GARO H
|
Chairman & CEO
|
2,790
|
$4.73
|
0.43%
|
|
9/4/2012
|
ARMEN GARO H
|
Chairman & CEO
|
2,845
|
$4.64
|
0.45%
|
|
8/29/2012
|
Sharp Shalini
|
Director
|
-288
|
$4.64
|
-0.37%
|
|
8/1/2012
|
ARMEN GARO H
|
Chairman & CEO
|
2,600
|
$5.08
|
0.41%
|
|
7/27/2012
|
ARMEN GARO H
|
Chairman & CEO
|
71,848
|
$4.55
|
12.73%
|
|
7/26/2012
|
Sharp Shalini
|
Director
|
625
|
$4.61
|
0.82%
|
|
7/26/2012
|
Valentine Karen
|
VP, General Counsel
|
416
|
$4.61
|
1.62%
|
|
7/26/2012
|
ARMEN GARO H
|
Chairman & CEO
|
1,389
|
$4.61
|
0.25%
|
|
7/26/2012
|
KLASKIN CHRISTINE M
|
VP, Finance
|
416
|
$4.61
|
2.00%
|
|
7/26/2012
|
Wentworth Kerry
|
VP, Clinical, Req & Quality
|
694
|
$4.61
|
2.29%
|
|
7/2/2012
|
ARMEN GARO H
|
Chairman & CEO
|
2,505
|
$5.27
|
0.45%
|
|
6/21/2012
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
-14,784
|
$5.05
|
-32.80%
|
|
6/21/2012
|
ARMEN GARO H
|
Chairman & CEO
|
-29,196
|
$5.05
|
-4.95%
|
|
6/21/2012
|
Valentine Karen
|
VP, General Counsel
|
-2,899
|
$5.05
|
-10.13%
|
|
6/21/2012
|
Sharp Shalini
|
Director
|
-4,107
|
$5.05
|
-5.11%
|
|
6/21/2012
|
KLASKIN CHRISTINE M
|
VP Finance
|
-3,810
|
$5.05
|
-15.49%
|
|
6/20/2012
|
Valentine Karen
|
VP, General Counsel
|
-1,564
|
$4.92
|
-5.18%
|
|
6/20/2012
|
Sharp Shalini
|
Director
|
-2,218
|
$4.92
|
-2.69%
|
|
6/20/2012
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
-14,151
|
$4.99
|
-23.90%
|
|
6/20/2012
|
KLASKIN CHRISTINE M
|
VP Finance
|
-3,646
|
$4.99
|
-12.91%
|
|
6/20/2012
|
ARMEN GARO H
|
Chairman & CEO
|
-15,793
|
$4.92
|
-2.61%
|
|
6/19/2012
|
KLASKIN CHRISTINE M
|
VP Finance
|
7,456
|
$5.26
|
35.88%
|
|
6/19/2012
|
ARMEN GARO H
|
Chairman & CEO
|
91,659
|
$5.26
|
17.84%
|
|
6/19/2012
|
KLASKIN CHRISTINE M
|
VP Finance
|
20,780
|
$5.26
|
278.70%
|
|
6/19/2012
|
Sharp Shalini
|
Director
|
12,713
|
$5.26
|
18.19%
|
|
6/19/2012
|
Valentine Karen
|
VP, General Counsel
|
10,050
|
$5.26
|
49.91%
|
|
6/19/2012
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
14,153
|
$5.26
|
31.41%
|
|
6/1/2012
|
ARMEN GARO H
|
Chairman & CEO
|
2,310
|
$5.71
|
0.45%
|
|
5/1/2012
|
ARMEN GARO H
|
Chairman & CEO
|
2,057
|
$6.42
|
0.40%
|
|
4/26/2012
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
695
|
$6.43
|
1.57%
|
|
4/26/2012
|
Valentine Karen
|
VP General Counsel
|
417
|
$6.43
|
2.11%
|
|
4/26/2012
|
Sharp Shalini
|
CFO
|
625
|
$6.43
|
0.90%
|
|
4/26/2012
|
KLASKIN CHRISTINE M
|
VP, Finance
|
417
|
$6.43
|
2.05%
|
|
4/26/2012
|
ARMEN GARO H
|
Chairman & CEO
|
1,389
|
$6.43
|
0.27%
|
|
4/2/2012
|
ARMEN GARO H
|
Chairman & CEO
|
2,563
|
$5.15
|
0.51%
|
|
4/2/2012
|
ARMEN GARO H
|
Chairman & CEO
|
48,894
|
$7.04
|
10.71%
|
|
3/30/2012
|
ARMEN GARO H
|
Chairman & CEO
|
-500,000
|
$6.60
|
-52.27%
|
|
3/15/2012
|
Valentine Karen
|
VP, General Counsel
|
2,904
|
$5.31
|
17.27%
|
|
3/15/2012
|
Sharp Shalini
|
CFO
|
4,862
|
$5.31
|
7.55%
|
|
3/15/2012
|
KLASKIN CHRISTINE M
|
VP, Finance
|
2,000
|
$5.31
|
10.89%
|
|
3/15/2012
|
ARMEN GARO H
|
Chairman & CEO
|
13,406
|
$5.31
|
1.42%
|
|
3/15/2012
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
6,077
|
$5.31
|
15.87%
|
|
3/1/2012
|
ARMEN GARO H
|
Chairman & CEO
|
4,204
|
$3.14
|
0.45%
|
|
2/1/2012
|
ARMEN GARO H
|
chairman & CEO
|
5,339
|
$2.47
|
0.57%
|
|
1/26/2012
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
694
|
$2.76
|
1.85%
|
|
1/26/2012
|
Valentine Karen
|
VP, General Counsel
|
417
|
$2.76
|
2.54%
|
|
1/26/2012
|
Sharp Shalini
|
CFO
|
625
|
$2.76
|
0.98%
|
|
1/26/2012
|
KLASKIN CHRISTINE M
|
VP, Finance
|
417
|
$2.76
|
2.32%
|
|
1/26/2012
|
ARMEN GARO H
|
Chairman & CEO
|
1,389
|
$2.76
|
0.15%
|
|
1/3/2012
|
ARMEN GARO H
|
Chairman & CEO
|
5,826
|
$2.27
|
0.63%
|
|
1/3/2012
|
KLASKIN CHRISTINE M
|
VP, Finance
|
12,789
|
$2.17
|
247.99%
|
|
1/3/2012
|
Sharp Shalini
|
CFO
|
22,121
|
$2.17
|
53.12%
|
|
1/3/2012
|
Valentine Karen
|
VP, General Counsel
|
15,208
|
$2.17
|
1,276.91%
|
|
1/3/2012
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
22,121
|
$2.17
|
142.92%
|
|
12/29/2011
|
KLASKIN CHRISTINE M
|
VP, Finance
|
-6,391
|
$2.00
|
-55.34%
|
|
12/29/2011
|
Valentine Karen
|
VP, General Counsel
|
-7,605
|
$1.98
|
-86.46%
|
|
12/29/2011
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
-8,939
|
$2.01
|
-36.61%
|
|
12/28/2011
|
Sharp Shalini
|
CFO
|
-1,711
|
$2.09
|
-3.95%
|
|
12/28/2011
|
KLASKIN CHRISTINE M
|
VP, Finance
|
-1,095
|
$2.09
|
-8.66%
|
|
12/28/2011
|
Valentine Karen
|
VP, General Counsel
|
-1,301
|
$2.09
|
-12.89%
|
|
12/28/2011
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
-1,893
|
$2.09
|
-7.19%
|
|
12/27/2011
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
-3,156
|
$2.14
|
-10.71%
|
|
12/27/2011
|
Valentine Karen
|
VP, General Counsel
|
-2,169
|
$2.14
|
-17.68%
|
|
12/27/2011
|
KLASKIN CHRISTINE M
|
VP, Finance
|
-1,824
|
$2.14
|
-12.61%
|
|
12/27/2011
|
Sharp Shalini
|
CFO
|
-2,853
|
$2.14
|
-6.17%
|
|
12/23/2011
|
KLASKIN CHRISTINE M
|
VP Finance
|
-511
|
$2.20
|
-3.41%
|
|
12/23/2011
|
Sharp Shalini
|
CFO
|
-795
|
$2.20
|
-1.69%
|
|
12/23/2011
|
Valentine Karen
|
VP, General Counsel
|
-608
|
$2.20
|
-4.72%
|
|
12/23/2011
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
-886
|
$2.20
|
-2.92%
|
|
12/22/2011
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
-1,716
|
$2.19
|
-5.35%
|
|
12/22/2011
|
Valentine Karen
|
VP, General Counsel
|
-1,177
|
$2.19
|
-8.38%
|
|
12/22/2011
|
Sharp Shalini
|
CFO
|
-1,548
|
$2.19
|
-3.19%
|
|
12/22/2011
|
KLASKIN CHRISTINE M
|
VP Finance
|
-993
|
$2.19
|
-6.22%
|
|
12/21/2011
|
Wentworth Kerry
|
VP, Clinical, Reg, & Quality
|
-3,414
|
$2.24
|
-9.62%
|
|
12/21/2011
|
Valentine Karen
|
VP, General Counsel
|
-2,348
|
$2.24
|
-14.32%
|
|
12/21/2011
|
Sharp Shalini
|
CFO
|
-3,087
|
$2.24
|
-5.98%
|
|
12/21/2011
|
KLASKIN CHRISTINE M
|
VP Finance
|
-1,975
|
$2.24
|
-11.00%
|
|
12/1/2011
|
ARMEN GARO H
|
Chairman & CEO
|
5,130
|
$2.57
|
0.56%
|